Company profile for Clinuvel Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a global biopharmaceutical company committed to developing drugs for the treatment of a range of severe skin disorders. People conceptualise ideas and products, and at CLINUVEL the integrity and quality of people – in that particular order – leads to meaningful outcomes, successes and eventually products to serve patients and a wider audience of users. At CLINUVEL there is a deep reservoir of expert knowledge beyond...
We are a global biopharmaceutical company committed to developing drugs for the treatment of a range of severe skin disorders. People conceptualise ideas and products, and at CLINUVEL the integrity and quality of people – in that particular order – leads to meaningful outcomes, successes and eventually products to serve patients and a wider audience of users. At CLINUVEL there is a deep reservoir of expert knowledge beyond the realm of this history and future to the company. We aim to use our knowledge to innovate products for smaller patient populations and larger audiences.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Australia
Address
Address
Level 11, 535 Bourke st, Melbourne Victoria 3000
Telephone
Telephone
+44 1372 860 765
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/08/22/3137673/0/en/CLINUVEL-preparing-upgrade-of-ADR-program-to-Level-II-Nasdaq-uplist.html

GLOBENEWSWIRE
22 Aug 2025

https://www.globenewswire.com/news-release/2025/05/07/3075714/0/en/CLINUVEL-recruits-200-patients-in-Phase-III-vitiligo-trial-CUV105.html

GLOBENEWSWIRE
07 May 2025

https://www.globenewswire.com/news-release/2025/03/04/3036144/0/en/Clinuvel-Introduces-Groundbreaking-Vitiligo-Program-at-the-World-s-Biggest-Dermatology-Meeting-AAD-2025.html

GLOBENEWSWIRE
03 Mar 2025

https://www.globenewswire.com/news-release/2024/06/18/2900070/0/en/Afamelanotide-in-fair-skinned-Parkinson-s-patients.html

GLOBENEWSWIRE
17 Jun 2024

https://www.globenewswire.com/news-release/2024/03/28/2853764/0/en/Photomedicine-Pioneer-CLINUVEL-Unveils-Clinical-Cosmetic-Ambitions-to-German-Investors.html

GLOBENEWSWIRE
28 Mar 2024

https://www.globenewswire.com//news-release/2024/03/05/2840064/0/en/Malibu-shines-a-light-on-CLINUVEL-s-pioneering-work-in-photomedicine.html

GLOBENEWSWIRE
04 Mar 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty